Updated Progression-Free Survival from PRESTO: a Phase 3 Randomized Study of Androgen Annihilation for High-Risk Biochemically Relapsed Prostate Cancer (AFT-19)
- Citation:
- Journal of Urology vol 209 (suppl 4) e1191
- Meeting Instance:
- AUA 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 4065
- Pharmas:
- Janssen
- Grants:
- Corr. Author:
- Authors:
- Rahul Aggarwal Scott E. Eggener Glenn Heller David Hillman Han Xiao Joel Picus Jennifer Wang Mary-Ellen Taplin Tanya Dorff Leonard Appleman Douglas Weckstein Akash Patnaik Alan Bryce Daniel Shevrin Susan Halabi James Mohler Daniel Anderson Arpit Rao Scott Tagawa Alan Tan Charles J. Ryan Michael J. Morris
- Networks:
- CA043, CA824, IL018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, LAPS-PA015, LAPS-TN008, LAPS-TX035, METROMIN, MN022, NH038, NY018, TX041
- Study
- AFT-19
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: